{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"91"}],"title":"Alive"},{"measurements":[{"groupId":"OG000","value":"10"}],"title":"Deceased"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"101"}],"units":"Participants"}],"description":"Logistic regression will be used to analyze the association between standardized phase angle and 60 day mortality. 60 day mortality rate is defined as the percent of patients no longer alive at 60 days after registration. Patients that are discharged to hospice care before 60 days without a known date of death will be counted towards 60 day mortality","groups":[{"description":"Patients undergo bioelectrical impedance phase angle measurement on day 1 of treatment. Patients with AML undergo a second measurement just prior to the nadir marrow. Patients also undergo bioelectrical impedance measurements prior to any invasive procedures (bone marrow biopsy, leukapheresis, PICC line placement, etc.).\n\nbioelectric impedance analysis: Undergo bioelectric impedance analysis","id":"OG000","title":"Diagnostic (Bioelectric Impedance Analysis)"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"60 days","title":"Treatment Related Mortality Defined as the Percent of Patients no Longer Alive at 60 Days After Registration","type":"PRIMARY","unitOfMeasure":"Participants"}